Abstract
Benzopyrone derivatives (Coumarins) are well known inhibitors of P-glycoprotein (P-gp) mediated efflux. The high expression level of these efflux proteins promotes the growth of breast cancer stem cells (CSCs). The activity of breast CSCs is directly affected by the inhibition of efflux proteins by benzopyrone derivatives. Ligand based pharmacophoric study and structure based docking studies have been exploited for assessing this inhibitory activity. Based on QSAR results, a three point pharmacophore comprising of one hydrogen bond acceptor (A) and two condensed aromatic groups (R) has been designed. The atom based QSAR study was conducted to predict partial least square (PLS) statistical factors for test and training data sets. Some specific amino acids have been demonstrated to be actively involved in the ligand protein interaction. These structural features of ligands and active site residues of target protein provide new pathways to develop therapeutically important drugs for the inhibition of breast cancer stem cells.
Keywords: Breast cancer stem cells, P-glycoprotein (P-gp), Efflux, Quantitative structure activity relationship (QSAR), Benzopyrones.
Current Bioinformatics
Title:3D-QSAR and Docking Simulation Studies of Some Benzopyrone Derivatives as Inhibitors for Breast Cancer Stem Cell Growth via PGlycoprotein Mediated Efflux
Volume: 11 Issue: 3
Author(s): Anushree Tripathi and Krishna Misra
Affiliation:
Keywords: Breast cancer stem cells, P-glycoprotein (P-gp), Efflux, Quantitative structure activity relationship (QSAR), Benzopyrones.
Abstract: Benzopyrone derivatives (Coumarins) are well known inhibitors of P-glycoprotein (P-gp) mediated efflux. The high expression level of these efflux proteins promotes the growth of breast cancer stem cells (CSCs). The activity of breast CSCs is directly affected by the inhibition of efflux proteins by benzopyrone derivatives. Ligand based pharmacophoric study and structure based docking studies have been exploited for assessing this inhibitory activity. Based on QSAR results, a three point pharmacophore comprising of one hydrogen bond acceptor (A) and two condensed aromatic groups (R) has been designed. The atom based QSAR study was conducted to predict partial least square (PLS) statistical factors for test and training data sets. Some specific amino acids have been demonstrated to be actively involved in the ligand protein interaction. These structural features of ligands and active site residues of target protein provide new pathways to develop therapeutically important drugs for the inhibition of breast cancer stem cells.
Export Options
About this article
Cite this article as:
Tripathi Anushree and Misra Krishna, 3D-QSAR and Docking Simulation Studies of Some Benzopyrone Derivatives as Inhibitors for Breast Cancer Stem Cell Growth via PGlycoprotein Mediated Efflux, Current Bioinformatics 2016; 11 (3) . https://dx.doi.org/10.2174/1574893611999160610125100
DOI https://dx.doi.org/10.2174/1574893611999160610125100 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functional Characterization of Chitin and Chitosan
Current Chemical Biology Synthesis and Biological Evaluation of New Quinoline-Based Thiazolyl Hydrazone Derivatives as Potent Antifungal and Anticancer Agents
Letters in Drug Design & Discovery Therapeutic Immunoconjugates. Which Cytotoxic Payload: Chemotherapeutic Drug (ADC) or Radionuclide (ARC) ?
Current Cancer Therapy Reviews Targeting miRNAs for Pancreatic Cancer Therapy
Current Pharmaceutical Design Malignant Phyllodes Tumors with Heterologous Sarcomatous Elements Presenting as Hyperechoic Masses on Ultrasonography: A Case Report
Current Medical Imaging Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract
Current Pharmaceutical Design Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer
Current Cancer Drug Targets Neuronal Differentiation of Neural Progenitor Cells by Intracellular Delivery of Synthetic Oligopeptide Derived from Von Hippel-Lindau Protein
Protein & Peptide Letters Personalized & Precision Medicine in Cancer: A Theranostic Approach
Current Radiopharmaceuticals Serial Analysis of Gene Expression in Eukaryotic Pathogens
Infectious Disorders - Drug Targets Macrophages in Immunopathology of Atherosclerosis: A Target for Diagnostics and Therapy
Current Pharmaceutical Design Nuclear Architecture and Gene Expression in the Quest for Novel Therapeutics
Current Pharmaceutical Design JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Current Medicinal Chemistry Genetic Variation at the Human MGMT Locus and its Biological Consequences
Current Pharmacogenomics Renin-angiotensin System Blockers and Modulation of Radiation-Induced Brain Injury
Current Drug Targets Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers
Current Medicinal Chemistry New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia
Current Cancer Drug Targets Anti-Cancer/Anti-Tumor
Current Bioactive Compounds Development of Colon Specific Microspheres of Flurbiprofen for Inflammatory Bowel Disease
Current Drug Delivery